A. Kornfeld

485 total citations
24 papers, 327 citations indexed

About

A. Kornfeld is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and General Health Professions. According to data from OpenAlex, A. Kornfeld has authored 24 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Economics and Econometrics, 5 papers in Pediatrics, Perinatology and Child Health and 3 papers in General Health Professions. Recurrent topics in A. Kornfeld's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (15 papers) and Pharmaceutical studies and practices (4 papers). A. Kornfeld is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (15 papers) and Pharmaceutical studies and practices (4 papers). A. Kornfeld collaborates with scholars based in France, Germany and United Kingdom. A. Kornfeld's co-authors include Mondher Toumi, Jean‐Michel Azorin, Paul Bebbington, Traolach Brugha, Reinhold Kilian, Sonia Johnson, Matthias C. Angermeyer, Dirk Heider, Christiane Roick and C. Rémuzat and has published in prestigious journals such as SHILAP Revista de lepidopterología, The British Journal of Psychiatry and The Journal of Nervous and Mental Disease.

In The Last Decade

A. Kornfeld

23 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Kornfeld France 9 163 143 86 85 35 24 327
Justo Pinzón-Espinosa Spain 10 186 1.1× 128 0.9× 16 0.2× 37 0.4× 27 0.8× 21 367
Ricarda Windisch Switzerland 4 138 0.8× 53 0.4× 36 0.4× 44 0.5× 28 0.8× 6 303
Pierre-Michel Llorca France 6 47 0.3× 161 1.1× 31 0.4× 48 0.6× 40 1.1× 9 257
Peter Parry Australia 10 132 0.8× 88 0.6× 30 0.3× 10 0.1× 28 0.8× 25 329
Jason Grossman United States 10 40 0.2× 94 0.7× 41 0.5× 42 0.5× 105 3.0× 17 437
Ka Chee Yip Hong Kong 8 214 1.3× 129 0.9× 19 0.2× 99 1.2× 65 1.9× 12 335
Felicia Forma United States 10 118 0.7× 51 0.4× 59 0.7× 39 0.5× 67 1.9× 32 455
Nicholas Freemantle United Kingdom 10 70 0.4× 72 0.5× 21 0.2× 35 0.4× 34 1.0× 20 360
Koushik Sinha Deb India 9 123 0.8× 157 1.1× 17 0.2× 69 0.8× 69 2.0× 41 429
Annalisa Campomori Italy 6 50 0.3× 57 0.4× 31 0.4× 44 0.5× 21 0.6× 9 181

Countries citing papers authored by A. Kornfeld

Since Specialization
Citations

This map shows the geographic impact of A. Kornfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Kornfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Kornfeld more than expected).

Fields of papers citing papers by A. Kornfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Kornfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Kornfeld. The network helps show where A. Kornfeld may publish in the future.

Co-authorship network of co-authors of A. Kornfeld

This figure shows the co-authorship network connecting the top 25 collaborators of A. Kornfeld. A scholar is included among the top collaborators of A. Kornfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Kornfeld. A. Kornfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gabriel, Sylvie, A. Kornfeld, Fernando Antoñanzas, et al.. (2017). Unlocking the potential of established products: toward new incentives rewarding innovation in Europe. SHILAP Revista de lepidopterología. 5(1). 1298190–1298190. 12 indexed citations
2.
Toumi, Mondher, et al.. (2017). Filling the gap in CNS drug development: evaluation of the role of drug repurposing. SHILAP Revista de lepidopterología. 5(1). 1299833–1299833. 31 indexed citations
4.
Rémuzat, C., C. Chouaïd, Pascal Auquier, et al.. (2016). Expected Impact of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) on Health Technology Assessment. Value in Health. 19(7). A358–A359. 3 indexed citations
5.
Toumi, Mondher, Szymon Jarosławski, Toyohiro Sawada, & A. Kornfeld. (2016). The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements. Applied Health Economics and Health Policy. 15(1). 5–11. 15 indexed citations
6.
Gabriel, Sylvie, et al.. (2015). Extension of Indication With Mature Products: Toward More Incentives Rewarding Innovation?. Value in Health. 18(7). A570–A570. 1 indexed citations
8.
Rémuzat, C., et al.. (2015). Conflict of interest in Health Technology Assessment decisions: case law in France and impact on reimbursement decisions. Journal of Market Access & Health Policy. 3(1). 25682–25682. 3 indexed citations
9.
Tol, Christiaan van der, et al.. (2014). A Testbed for Model Development. AGUFM. 2014. 1 indexed citations
10.
Kornfeld, A., et al.. (2014). Access To Orphan Drugs in France: The Case Of Siklos For The Treatment of Sickle Cell Syndrome Before The Council of State. Value in Health. 17(7). A453–A453. 1 indexed citations
11.
Rémuzat, C., et al.. (2014). Price Dynamics Of External Reference Pricing-Based Systems In Europe. Value in Health. 17(3). A11–A11. 3 indexed citations
12.
Rémuzat, C., et al.. (2014). Comparative Analysis of Hta Decisions, Price and Reimbursement Level of Orphan Drugs In France and Italy. Value in Health. 17(7). A539–A540. 1 indexed citations
13.
Kornfeld, A., et al.. (2014). Conflict Of Interest in HTA Recommendations and Case Law In France. Value in Health. 17(7). A450–A450. 1 indexed citations
14.
Kornfeld, A., et al.. (2014). Health Technology Assessments In Oncology: Crizotinib Case Study. Value in Health. 17(7). A661–A661. 1 indexed citations
15.
Kornfeld, A., et al.. (2014). Gap Between Payers And Regulators Management Of Risk Prevents And Delays Patient Access To New Therapy. Value in Health. 17(3). A15–A15. 3 indexed citations
16.
Kornfeld, A., et al.. (2013). Coverage with Evidence Development in Sweden – Formality or Effective Way to Reduce Uncertainty?. Value in Health. 16(7). A487–A488. 1 indexed citations
17.
Rémuzat, C., et al.. (2013). Dispensation Channels of Anti-TNFs in Inflammatory Bowel Disease. Value in Health. 16(7). A501–A501. 1 indexed citations
18.
Marwaha, Steven, Sonia Johnson, Paul Bebbington, et al.. (2008). Correlates of Subjective Quality of Life in People With Schizophrenia. The Journal of Nervous and Mental Disease. 196(2). 87–94. 38 indexed citations
19.
Roick, Christiane, Dirk Heider, Paul Bebbington, et al.. (2007). Burden on caregivers of people with schizophrenia: Comparison between Germany and Britain. The British Journal of Psychiatry. 190(4). 333–338. 115 indexed citations
20.
Bebbington, Paul, Matthias C. Angermeyer, Jean‐Michel Azorin, et al.. (2005). The European Schizophrenia Cohort. Social Psychiatry and Psychiatric Epidemiology. 40(9). 707–717. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026